Who Owns THERAVANCE BIOPHARMA INC (TBPH)? -- Institutional Holders (2026-06-30)

204 institutions reported holding $826.1M of THERAVANCE BIOPHARMA INC (TBPH) in SEC 13F filings for 2026-06-30. Largest institutional holders: Madison Avenue Partners, LP ($156.6M), Weiss Asset Management LP ($126.8M), BlackRock, Inc. ($77.6M), Newtyn Management, LLC ($58.4M), Irenic Capital Management LP ($46.9M). Source: SEC Form 13F.

Rank	Institution	Value	Shares	Change
1	Madison Avenue Partners, LP	$156.6M	9.2M	Trimmed
2	Weiss Asset Management LP	$126.8M	7.5M	Hold
3	BlackRock, Inc.	$77.6M	4.6M	Added
4	Newtyn Management, LLC	$58.4M	3.4M	Trimmed
5	Irenic Capital Management LP	$46.9M	2.8M	Hold
6	VANGUARD GROUP INC	$42.3M	2.5M	Trimmed
7	STATE STREET CORP	$22.6M	1.3M	Added
8	TWO SIGMA INVESTMENTS, LP	$20.8M	1.2M	Trimmed
9	D. E. Shaw & Co., Inc.	$20.2M	1.2M	Added
10	ACADIAN ASSET MANAGEMENT LLC	$20.0M	1.2M	Trimmed
11	GEODE CAPITAL MANAGEMENT, LLC	$19.0M	1.1M	Trimmed
12	DIMENSIONAL FUND ADVISORS LP	$17.7M	1.0M	Added
13	MACKENZIE FINANCIAL CORP	$16.8M	985,848	Added
14	MORGAN STANLEY	$12.0M	705,202	Added
15	Oasis Management Co Ltd.	$9.9M	583,490	Hold
16	CITADEL ADVISORS LLC	$9.1M	537,468	Added
17	UBS Group AG	$8.3M	488,309	Trimmed
18	Qube Research & Technologies Ltd	$7.3M	429,813	Added
19	NORTHERN TRUST CORP	$6.9M	404,356	Added
20	Jupiter Topco LLC	$6.6M	387,493	New
21	GOLDMAN SACHS GROUP INC	$5.8M	339,960	Trimmed
22	Sixth Street Partners Management Company, L.P.	$5.5M	321,154	New
23	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$5.5M	321,154	Added
24	GLAZER CAPITAL, LLC	$5.1M	301,834	New
25	JPMORGAN CHASE & CO	$3.8M	221,846	Added

Source: SEC Form 13F filings · as of 2026-06-30